Global Wellness Supplements Market Valuation and Growth Prospects: $11.03 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the wellness supplements market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Wellness Supplements Market Size?

The cellular immunotherapy market has shown rapid expansion in its size over recent years. It is anticipated to increase from $5.72 billion in 2024 to $6.56 billion in 2025, with a compound annual growth rate (CAGR) of 14.7%. Historical growth in this sector can be attributed to advancements in cancer treatment, successful clinical outcomes, regulatory approvals, and the rising incidence of targeted diseases.

The cellular immunotherapy market is projected for significant expansion in the coming years, anticipated to reach “$11.03 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the forecast period include the expansion into solid tumors, enhancements in manufacturing processes, robust healthcare infrastructure, and increased research funding. Key trends expected within this period encompass significant investments in research and development, emerging clinical trial data, and the rise of combination therapies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

What Core Market Drivers Are Expanding The Wellness Supplements Industry?

The cellular immunotherapy market is expected to expand over the forecast period, driven by increasing research and successful clinical trials in cellular immunotherapy. Companies are focusing on developing new cellular immunotherapies for treating different diseases. For instance, in June 2022, a report published by the Cancer Research Institute, a US-based nonprofit organization devoted solely to developing immunotherapy for the prevention, treatment, and eventual eradication of all cancers, indicated that as of April 2022, the worldwide immuno-oncology pipeline contained 2,756 active cell therapy drugs. This figure represents an increase of 36% from the 2021 landscape analysis, which had revealed 2,031 such agents, though it also marked a slight slowdown from the 43% growth recorded in the previous year. The rapid growth observed in the development of cellular immunotherapy at clinical and preclinical stages in 2020, when compared to 2019, is projected to expand the overall landscape of cellular immunotherapy. Subsequently, this expansion is expected to generate higher revenues for the growth of the cellular immunotherapy market.

What Segment Insights Are Highlighted In The Wellness Supplements Market Report?

The cellular immunotherapy market covered in this report is segmented –

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications

3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Subsegments:

1) By Tumour-Infiltrating Lymphocyte (TIL) Therapy: Autologous TIL Therapy, Allogeneic TIL Therapy, Other TIL Therapy

2) By Engineered T Cell Receptor (TCR) Therapy: Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy, Other Engineered TCR Therapy

3) By Chimeric Antigen Receptor (CAR) T Cell Therapy: Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies, Other CAR T Cell Therapy

4) By Natural Killer (NK) Cell Therapy: Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications, Other NK Cell Therapy

Which Notable Trends Are Transforming The Wellness Supplements Market Outlook?

Companies within the cellular immunotherapy market are prioritizing the creation of off-the-shelf allogeneic therapies for advanced and innovative cancer treatment. These off-the-shelf allogeneic therapies are derived from donor cells, in contrast to autologous therapy which utilizes a patient’s own cells. Their standardized nature offers advantages such as economic efficiency, large-scale production, rapid manufacturing, and robust quality control. For instance, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company dedicated to drug discovery, development, manufacturing, and commercialization, announced that the US Food and Drug Administration (FDA) granted expedited approval for Kymriah (tisagenlecleucel) to treat adult patients with relapsed or refractory (r/r) follicular lymphoma (FL) following two or more lines of systemic therapy. Additionally, Acepodia, a US-based next-generation cell immuno-technology company, initiated a phase 1 clinical trial in August 2020 to evaluate ACE1702, an allogeneic, off-the-shelf NK cell therapy, for the treatment of solid tumors.

Which Firms Are Driving Innovation Within The Wellness Supplements Market?

Major companies operating in the cellular immunotherapy market include Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

What Regional Trends Are Shaping Growth In The Wellness Supplements Market?

North America was the largest region in the cellular immunotherapy market in 2024. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3435&type=smp

Browse Through More Reports Similar to the Global Wellness Supplements Market 2025, By The Business Research Company

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795